Fold increase |
|
|
|
2.02 |
17q |
CBX1 |
Chromobox homolog 1 (HP1 β homolog Drosophila) |
2.20 |
3p21.31 |
SPCS1 |
Signal peptidase complex subunit 1 homolog (Saccharomyces cerevisiae) |
2.34 |
17q23.1-q23.3 |
KPNA2 |
Karyopherin α 2 (RAG cohort 1, importin α 1) |
2.50 |
22q12.3 |
YWHAH |
Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, η polypeptide |
2.55 |
2q33-q34 |
EEF1B2 |
Eukaryotic translation elongation factor 1 β 2 |
2.71 |
8p21.2 |
ENTPD4 |
Ectonucleoside triphosphate diphosphohydrolase 4 |
2.73 |
7p15-p12 |
ACTB |
Actin, β |
2.79 |
15q13-q14 |
SCG5 |
Secretogranin V (7B2 protein) |
2.85 |
6p21.1 |
SRF |
Serum response factor (c-fos serum response element-binding transcription factor) |
2.86 |
17q21.3 |
NME1 |
Nonmetastatic cells 1, protein (NM23A) expressed in |
2.91 |
8p21-p12 |
EPHX2 |
Epoxide hydrolase 2, cytoplasmic |
2.93 |
9q22-q31 |
ZNF189 |
Zinc finger protein 189 |
2.98 |
13q14.3 |
ITM2B |
Integral membrane protein 2B |
3.00 |
8q21 |
TPD52 |
Tumor protein D52 |
3.11 |
1q21 |
MLLT11 |
Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11 |
3.12 |
9q34.11 |
RABEPK |
Rab9 effector protein with kelch motifs |
3.34 |
9q21.13 |
RFK |
Riboflavin kinase |
3.34 |
1p36.1 |
DDOST |
Dolichyl-diphosphooligosaccharide-protein glycosyltransferase |
3.40 |
Xp11.2 |
RBM3 |
RNA binding motif (RNP1, RRM) protein 3 |
3.42 |
7q21-q22 |
SGCE |
Sarcoglycan, ϵ |
3.43 |
11p13 |
RCN1 |
Reticulocalbin 1, EF-hand calcium binding domain |
3.47 |
12q22-q23 |
DUSP6 |
Dual specificity phosphatase 6 |
3.51 |
20q13.2-q13.3 |
GNAS |
GNAS complex locus |
3.66 |
10q11.21 |
BMS1 |
BMS1 homolog, ribosome assembly protein (yeast) |
3.68 |
9q34.11 |
ARPC5 L |
Actin-related protein 2/3 complex, subunit 5-like |
3.70 |
19p13.2 |
ZNF177 |
Zinc finger protein 177 |
3.74 |
10p13 |
CELF2 |
CUGBP, Elav-like family member 2 |
3.76 |
19q13.1 |
SPINT2 |
Serine peptidase inhibitor, Kunitz type, 2 |
3.90 |
18p11.2 |
IMPA2 |
Inositol(myo)-1(or 4)-monophosphatase 2 |
3.91 |
14q24.1-q24.3 |
ARG2 |
Arginase, type II |
3.92 |
14q11.2 |
IRF9 |
Interferon regulatory factor 9 |
3.95 |
1q21 |
SHC1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
4.21 |
19p13.3 |
MIDN |
Midnolin |
4.30 |
12q12-q13 |
CD63 |
CD63 molecule |
4.33 |
1p31.3 |
LEPROT |
Leptin receptor overlapping transcript |
4.47 |
12q12 |
SLC38A1 |
Solute carrier family 38, member 1 |
4.51 |
11p11 |
GNG3 |
Guanine nucleotide binding protein (G protein), γ 3 |
4.59 |
5q13 |
THBS4 |
Thrombospondin 4 |
5.05 |
1q21.3 |
PBXIP1 |
Pre-B-cell leukemia homeobox interacting protein 1 |
5.06 |
15q21-q22.2 |
B2M |
β-2-microglobulin |
5.53 |
1p31.2-p31.1 |
GADD45A |
Growth arrest and DNA-damage-inducible, α |
5.91 |
Xq13.1-q28 |
IL13RA2 |
Interleukin 13 receptor, α 2 |
6.02 |
9q13 |
PIP5K1B |
Phosphatidylinositol-4-phosphate 5-kinase, type I, β |
6.05 |
3q13.33 |
SLC15A2 |
Solute carrier family 15 (H+/peptide transporter), member 2 |
6.74 |
6q23 |
SGK1 |
Serum/glucocorticoid regulated kinase 1 |
6.80 |
19q13.32 |
FOSB |
FBJ murine osteosarcoma viral oncogene homolog B |
7.09 |
12q24.13 |
ERP29 |
Endoplasmic reticulum protein 29 |
7.15 |
15q24-q25 |
CTSH |
Cathepsin H |
8.72 |
12q21 |
NTS |
Neurotensin |
9.10 |
6p21.3 |
HLA-B |
Major histocompatibility complex, class I, B |
9.58 |
6q27 |
THBS2 |
Thrombospondin 2 |
10.57 |
10q25 |
DUSP5 |
Dual specificity phosphatase 5 |
11.08 |
7q22 |
VGF |
VGF nerve growth factor inducible |
11.78 |
8q23-q24 |
PENK |
Proenkephalin |
Fold decrease |
|
|
|
0.09 |
9p22 |
SH3GL2 |
SH3-domain GRB2-like 2 |
0.20 |
16q22.1 |
CDH1 |
Cadherin 1, type 1, E-cadherin (epithelial) |
0.22 |
16q22.1 |
HP |
Haptoglobin |
0.32 |
17q12-q21.1 |
IGFBP4 |
IGF binding protein 4 |
0.36 |
11p11.2 |
MDK |
Midkine (neurite growth-promoting factor 2) |
0.45 |
Xq22-q24 |
PGRMC1 |
Progesterone receptor membrane component 1 |
0.60 |
1p13.3 |
GSTM2 |
Glutathione S-transferase μ 2 (muscle) |